Dr. Strader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Smith 247a
Burlington, VT 05401Phone+1 802-847-2554
Education & Training
- University of MarylandResidency, Internal Medicine, 1987 - 1990
- Georgetown University School of MedicineClass of 1987
Certifications & Licensure
- NY State Medical License 2021 - 2026
- VT State Medical License 2002 - 2026
- CA State Medical License 2018 - 2025
- MD State Medical License 1989 - 2003
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 2 citationsUtility of laboratory monitoring during hepatitis C treatment with ribavirin-free direct-acting antiviral regimens.Jocelyn R. VanOpdorp, Nicholas Ferrentino, Doris B. Strader, Steven D. Lidofsky
Journal of Viral Hepatitis. 2019-06-01 - 25 citationsA brief history of the treatment of viral hepatitis C.Doris B. Strader, Leonard B. Seeff
Clinical Liver Disease. 2012-02-01 - 856 citationsAn Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver DiseasesMarc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas, Leonard B. Seeff
Hepatology. 2011-10-01
Press Mentions
- The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
- Pexidartinib Supported by FDA's ODAC for Tenosynovial Giant Cell TumorsMay 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: